The United States and the Russian Federation have come to an agreement! The sanctions need to end, right here and right now, because the two greatest powers in the world are standing together on a matter of great global importance! Well… not so much. However, both countries are attempting to use propaganda in a very aggressive and […]
Medical marijuana is a touchy subject and many people are still on the fence about whether it’s a legitimate medicine and should be legalized. If you’re one of those people who remain unconvinced, perhaps this new study will change your mind.
http://naturalsociety.com/wp-content/uploads/Medical_Cannabis_Laws_and_Opioid_Prescribing_in_the_Medicare_Part_D_Population.mp3
Research shows that fewer opioid prescriptions are written in states that have access to legal marijuana. Could there be a connection between decreased opioid use and marijuana legalization? [1]
Trump promised to rein in drug prices. It was his only sensible campaign promise.
But the plan he announced Friday does little but add another battering ram to his ongoing economic war against America’s allies.
He calls it “American patients first,” and takes aim at what he calls “foreign freeloading.” The plan will pressure foreign countries to relax their drug price controls.
The U.S. Food and Drug Administration (FDA) confirms the popular Johnson & Johnson (J&J) diabetes drug Invokana (Invokamet, Invokamet XR) increases the risk of foot and leg amputations in people with Type 2 diabetes. [1]
The results of 2 clinical trials showed leg and foot amputations occurred about twice as often in patients taking Invokana (generic name: canagliflozin) as those given a placebo, according to an announcement on the FDA’s website. [2]
The FDA gave permission on November 29 for large-scale, Phase 3 clinical trials of Ecstasy for people suffering with post-traumatic stress disorder, or PTSD. Many people swear the currently-illicit street drug has saved their lives, and if the trial is successful, it would establish Ecstasy as a legitimate prescription drug. [1]
Preliminary trials of Ecstasy, also called MDMA, for PTSD have been successful, but a large-scale trial is necessary before the FDA can approve it. [2]
A Gooding, Idaho, mom lost custody of her children and is facing charges after treating her daughter’s seizures with marijuana butter. [1]
Three-year-old Madyson began suffering seizures and hallucinations in early October after coming off of the prescription anti-psychotic drug Risperdal, which was being used to treat a history of seizures.
Madyson’s mom, Kelsey Osborne, explained:
“They [the seizures] would stop and come back, stop and come back with the hallucinations and everything else.” [2]
A new report was issued by the California State Auditor suggesting that too many children in foster care are unnecessarily taking psychotropic drugs, and many without adequate supervision. [1]
The report focused on foster children in California, however, this is more problematic than you might expect, as the state runs the largest foster care system in the United States.
The U.S. Drug Enforcement Administration (DEA) announced on October 4th, 2016 that plans to reduce opioid manufacturing by 25% next year are underway, citing a shrinking market and the epidemic of abuse as primary reasons.
The official change, or Final Order, has been published in the Federal Register. And, as The Verge reports:
On October 12, the U.S. Drug Enforcement Administration (DEA) said in a notice to be published in the Federal Register that it has formally withdrawn plans to ban kratom, an herb used by many as a natural medicine.
In August, the DEA outlined plans to classify mitragynine and 7-hydroxymitragynine, two active compounds in kratom, as Schedule I substances, alongside heroin, LSD, and (inexplicably) marijuana.
